An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Quantum-Si to Present at the 2022 UBS Global Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Quantum-Si Incorporated (NASDAQ: QSI) is set to present at the 2022 UBS Global Healthcare Conference from May 23-25, 2022, at the Lotte New York Palace. The presentation is scheduled for May 23, 2022, at 3:30 pm ET. Quantum-Si specializes in single molecule protein sequencing and is advancing the field of proteomics with innovative semiconductor technology. The event will be accessible via a live and archived webcast on the Quantum-Si Investors website.
Positive
None.
Negative
None.
GUILFORD, Conn.--(BUSINESS WIRE)--
May 10, 2022-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the 2022 UBS Global Healthcare Conference taking place at the Lotte New York Palace, New York, NY, on May 23-25, 2022.
Quantum-Si’s management is scheduled to present on Monday, May 23, 2022 at 3:30 pm ET.
A live and archived webcast of the event will be available in the Investors section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.
